| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | -53.0% | -74.1% |
| Cost of Revenue | $3.5M | +98.7% | +1.2% |
| Gross Profit | -$2.3M | -343.0% | -258.7% |
| R&D Expense | $157K | +7.5% | -8.7% |
| SG&A Expense | $807K | +13.7% | -15.9% |
| Operating Income | -$3.9M | -3424.5% | -9792.5% |
| Net Income | -$4.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4K | -97.7% | -99.2% |
| Accounts Receivable | $856K | -57.9% | -71.0% |
| Inventory | $10.9M | -16.2% | -27.5% |
| Current Assets | $11.8M | -22.4% | -36.6% |
| Total Assets | $12.3M | -25.4% | -41.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$589K | — | — |
| Capital Expenditures | $18K | — | — |
| Investing Cash Flow | -$18K | — | — |
| Financing Cash Flow | $95K | — | — |
| Free Cash Flow | -$607K | — | — |
| -1407.4% |
| — |
| EPS (Basic) | -$1.63 | -1381.8% | — |
| EPS (Diluted) | -$1.63 | -1381.8% | — |
| $9.4M |
| -0.4% |
| +10.9% |
| Total Liabilities | $9.4M | -1.2% | +1.0% |
| Stockholders' Equity | $2.9M | -58.5% | -74.9% |